心脏术后重症监护室心肌肌球蛋白结合蛋白C释放特征
该研究建立酶联免疫吸附法检测血cMyBP-C,连续纳入151例心脏手术患者,于术前、ICU到达时、术后2-48小时及出院前检测。结果显示cMyBP-C在术后即刻达峰(为术前3.8倍),24小时内骤降,出院前仍高于术前;非体外循环冠脉搭桥释放最少,多瓣膜手术释放最高。
要点
- cMyBP-C术后0小时达峰,为术前3.8倍,24小时内骤降
- 非体外循环冠脉搭桥cMyBP-C释放最少,多瓣膜手术最高
- cMyBP-C与hs-cTnT均与手术方式、ICU及住院时间相关
核心结论
- 循环cMyBP-C是评估心脏手术创伤的有前景的新型生物标志物。
研究设计与样本
- 建立双单克隆抗体酶联免疫吸附法检测血cMyBP-C,连续纳入151例心脏手术患者。
- 于术前、ICU到达时(术后0小时)、术后2-48小时及出院前检测血cMyBP-C。
主要发现
- cMyBP-C在术后0小时达峰,为术前3.8倍,24小时内骤降,出院前仍高于术前。
- 术后cMyBP-C与hs-cTnT、肌酸激酶、肌红蛋白及肌酸激酶MB同工酶正相关。
- 非体外循环冠脉搭桥cMyBP-C释放较少,瓣膜置换/成形术释放较高,多瓣膜手术尤其高。
- cMyBP-C与hs-cTnT均与手术技术、术后ICU停留及住院时间相关。
关键数值与推荐
- 所建立免疫法可检测人cMyBP-C,范围0至1000 ng/L。
- cMyBP-C术后0小时达峰,为术前3.8倍。
临床怎么用
- 心脏术后可检测cMyBP-C辅助评估心肌创伤程度。
- 不同手术方式cMyBP-C释放水平不同,解读时需结合术式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac surgical procedures produce iatrogenic myocardial cell injury with necrosis that result in an obligatory release of biomarkers. Cardiac myosin binding protein C (cMyBP-C) has recently emerged as a specific and sensitive biomarker in patients with acute myocardial injury. We therefore aimed to investigate the release profiles of cMyBP-C after cardiac surgical procedures. METHODS: Enzyme-linked immunosorbent assay to detect blood cMyBP-C was established by using two monoclonal antibodies against N-terminus of human cMyBP-C. Consecutive patients undergoing cardiac operations (N = 151) were recruited in this study. Blood cMyBP-C was assayed preoperatively, at intensive care unit arrival (0 hour after the operation), at 2 to 48 hours, and before discharge. The characteristics and detailed surgical procedure were recorded. RESULTS: The established immunoassay was capable of detecting human cMyBP-C (0 to 1000 ng/L). The released cMyBP-C peaked immediately after cardiac surgery (0 h), attaining 3.8-fold higher than before the operation, dropped abruptly within 24 hours, and stayed at a higher level until discharge. Postoperative cMyBP-C levels correlated positively with high-sensitivity cardiac troponin T (hs-cTnT), creatine kinase, myoglobin, and creatine kinase MB isoenzyme. Different cardiac surgical procedures were characterized by different levels of release of cardiac biomarkers. Isolated off-pump coronary artery bypass grafting was associated with the smaller amount of cMyBP-C release, whereas valve replacement/plasty surgery produced higher release, in particular the multiple-valve surgery. Both cMyBP-C and hs-cTnT correlated with surgical techniques, postoperative intensive care unit stay, and hospital stay. CONCLUSIONS: Circulating cMyBP-C is a promising novel biomarker for evaluating cardiac surgical trauma in patients undergoing a cardiac operation.
引用
- Chen XJ, Zhang W, Bian ZP, et al. Cardiac Myosin-Binding Protein C Release Profile After Cardiac Surgery in Intensive Care Unit. Ann Thorac Surg. 2019. PMID: 31034826. doi:10.1016/j.athoracsur.2019.03.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。